<?xml version="1.0" ?>
<rss version="2.0">
<channel>
<title>MPR News Wire</title><link>http://www.prescribingreference.com</link><description>Latest MPR Drug News and New Products.</description><item>
<title>FDA APPROVES TACLONEX SCALP FOR PSORIASIS</title>
<description>Warner Chilcott and LEO Pharma have received FDA approval for Taclonex Scalp (calcipotriene 0.005% and betamethasone dipropionate 0.064% topical suspension), a once-daily therapy for the treatment of moderate-to-severe psoriasis vulgaris of the scalp in adults. </description>
<link>http://www.prescribingreference.com/news/showNews/which/FDAApprovesTaclonexScalpForPsoriasis5123/</link>
<guid>http://www.prescribingreference.com/news/showNews/which/FDAApprovesTaclonexScalpForPsoriasis5123/</guid>
</item>
<item>
<title>GENERIC YASMIN APPROVED</title>
<description>Barr has received approval to market a generic version of Bayer&#039;s oral contraceptive, Yasmin (drospirenone and ethinyl estradiol tablets).  </description>
<link>http://www.prescribingreference.com/news/showNews/which/GenericYasminApproved5124/</link>
<guid>http://www.prescribingreference.com/news/showNews/which/GenericYasminApproved5124/</guid>
</item>
<item>
<title>NOVOSEVEN RT APPROVED TO CONTROL SURGICAL BLEEDING</title>
<description>The FDA has approved Novo Nordisk&#039;s NovoSeven RT (recombinant human coagulation factor VIIa), another formulation of NovoSeven, that can be stored at room temperature (up to 81&amp;deg;F) for up to two years.</description>
<link>http://www.prescribingreference.com/news/showNews/which/NovoSevenRTApprovedToControlSurgicalBleeding5122/</link>
<guid>http://www.prescribingreference.com/news/showNews/which/NovoSevenRTApprovedToControlSurgicalBleeding5122/</guid>
</item>
<item>
<title>ORAVERSE APPROVED FOR DENTAL ANESTHETIC RECOVERY</title>
<description>Novalar has received approval to market OraVerse (phentolamine mesylate injection) for the reversal of soft-tissue anesthesia and the associated functional deficits resulting from a local dental anesthetic.</description>
<link>http://www.prescribingreference.com/news/showNews/which/OraVerseApprovedForDentalAnestheticRecovery5121/</link>
<guid>http://www.prescribingreference.com/news/showNews/which/OraVerseApprovedForDentalAnestheticRecovery5121/</guid>
</item>
<item>
<title>ABILIFY GAINS EXPANDED BIPOLAR AND SCHIZOPHRENIA INDICATIONS</title>
<description>The FDA has approved Abilify (aripiprazole, from Bristol-Myers Squibb and Otsuka) for the maintenance treatment of manic and mixed episodes associated with bipolar I disorder, with or without psychotic features, in children 10-17 years of age and for the maintenance treatment of schizophrenia in adolescents 13-17 years of age. </description>
<link>http://www.prescribingreference.com/news/showNews/which/AbilifyGainsExpandedBipolarAndSchizophreniaIndications5091/</link>
<guid>http://www.prescribingreference.com/news/showNews/which/AbilifyGainsExpandedBipolarAndSchizophreniaIndications5091/</guid>
</item>
<item>
<title>OMNARIS</title>
<description>Ciclesonide nasal spray for allergic rhinitis</description>
<link>http://www.prescribingreference.com/products/showProducts/which/Omnaris/</link>
<guid>http://www.prescribingreference.com/products/showProducts/which/Omnaris/</guid>
</item>
<item>
<title>FDA APPROVES STRATTERA FOR ADHD MAINTENANCE</title>
<description>The FDA has approved Strattera (atomoxetine HCl capsules, from Eli Lilly) for maintenance treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children &amp;ge;6 years of age.</description>
<link>http://www.prescribingreference.com/news/showNews/which/FDAApprovesStratteraForADHDMaintenance5081/</link>
<guid>http://www.prescribingreference.com/news/showNews/which/FDAApprovesStratteraForADHDMaintenance5081/</guid>
</item>
<item>
<title>GENERIC DOVONEX SCALP SOLUTION LAUNCHED</title>
<description>Fougera has received FDA approval to market the generic version of Warner-Chilcott&#146;s Dovonex Scalp Solution (calcipotriene topical solution). </description>
<link>http://www.prescribingreference.com/news/showNews/which/GenericDovonexScalpSolutionLaunched5061/</link>
<guid>http://www.prescribingreference.com/news/showNews/which/GenericDovonexScalpSolutionLaunched5061/</guid>
</item>
<item>
<title>KING DISCONTINUES TILADE INHALER </title>
<description>King Pharmaceuticals has decided to discontinue the manufacturing of Tilade Inhaler (nedocromil sodium inhalation aerosol).</description>
<link>http://www.prescribingreference.com/news/showNews/which/KingDiscontinuesTiladeInhaler5051/</link>
<guid>http://www.prescribingreference.com/news/showNews/which/KingDiscontinuesTiladeInhaler5051/</guid>
</item>
<item>
<title>METAMUCIL PINK LEMONADE AVAILABLE</title>
<description>Procter &amp; Gamble has added a sugar-free, pink lemonade flavor to its Metamucil line-up of fiber supplement powder products.</description>
<link>http://www.prescribingreference.com/news/showNews/which/MetamucilPinkLemonadeAvailable5052/</link>
<guid>http://www.prescribingreference.com/news/showNews/which/MetamucilPinkLemonadeAvailable5052/</guid>
</item>
</channel>
</rss>